Combination therapy for treatment of myeloproliferative neoplasms Grant US-11833155-B2 United States of America 05 Dec 2023
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus… Grant US-11744832-B2 United States of America 05 Sep 2023
Sustained-release dosage forms of ruxolitinib Grant US-11576865-B2 United States of America 14 Feb 2023